245 related articles for article (PubMed ID: 19476269)
1. Current status and future potential of advanced technologies in radiation oncology. Part 2. State of the science by anatomic site.
Vikram B; Coleman CN; Deye JA
Oncology (Williston Park); 2009 Apr; 23(4):380-5. PubMed ID: 19476269
[TBL] [Abstract][Full Text] [Related]
2. Current status and future potential of advanced technologies in radiation oncology. Part 1. Challenges and resources.
Vikram B; Coleman CN; Deye JA
Oncology (Williston Park); 2009 Mar; 23(3):279-83. PubMed ID: 19418829
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials and radiation oncology technologies.
Michalski JM; Bosch WR; Purdy JA
Oncology (Williston Park); 2009 Apr; 23(4):386, 389. PubMed ID: 19476270
[No Abstract] [Full Text] [Related]
4. Evaluating advanced technologies in radiation oncology: when and how should randomized trials be done?
Sanguineti G; DeWeese TL
Oncology (Williston Park); 2009 Apr; 23(4):390, 393. PubMed ID: 19476271
[No Abstract] [Full Text] [Related]
5. Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain.
Marcu LG
Cancer Treat Rev; 2010 Dec; 36(8):606-14. PubMed ID: 20494524
[TBL] [Abstract][Full Text] [Related]
6. [Which intensity modulated radiation therapy? From "step and shoot" to volumetric modulated arc therapy, point of view of the radiation oncologist].
Vieillot S; Fenoglietto P; Moscardo CL; Aillères N; Lemanski C; Dubois JB; Azria D
Cancer Radiother; 2010 Oct; 14(6-7):550-3. PubMed ID: 20724189
[TBL] [Abstract][Full Text] [Related]
7. Opportunities and challenges in the era of molecularly targeted agents and radiation therapy.
Lin SH; George TJ; Ben-Josef E; Bradley J; Choe KS; Edelman MJ; Guha C; Krishnan S; Lawrence TS; Le QT; Lu B; Mehta M; Peereboom D; Sarkaria J; Seong J; Wang D; Welliver MX; Coleman CN; Vikram B; Yoo S; Chung CH; ;
J Natl Cancer Inst; 2013 May; 105(10):686-93. PubMed ID: 23503600
[TBL] [Abstract][Full Text] [Related]
8. [Approaches to individual radiotherapy in breast cancer: individual risk estimation and individualized techniques].
Kahán Z; Varga Z; Csenki M; Szabó J; Szil E; Fekete G; Hideghéty K; Boda K; Thurzó L
Orv Hetil; 2007 May; 148(18):833-41. PubMed ID: 17468066
[TBL] [Abstract][Full Text] [Related]
9. Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop.
Smith GL; Ganz PA; Bekelman JE; Chmura SJ; Dignam JJ; Efstathiou JA; Jagsi R; Johnstone PA; Steinberg ML; Williams SB; Yu JB; Zietman AL; Weichselbaum RR; Tina Shih YC
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):450-461. PubMed ID: 28011046
[TBL] [Abstract][Full Text] [Related]
10. TCP and NTCP in preclinical and clinical research in Europe.
Baumann M; Petersen C; Krause M
Rays; 2005; 30(2):121-6. PubMed ID: 16294904
[TBL] [Abstract][Full Text] [Related]
11. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
12. Potential Morbidity Reduction With Proton Radiation Therapy for Breast Cancer.
Braunstein LZ; Cahlon O
Semin Radiat Oncol; 2018 Apr; 28(2):138-149. PubMed ID: 29735190
[TBL] [Abstract][Full Text] [Related]
13. Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.
Al-Hallaq HA; Chmura S; Salama JK; Winter KA; Robinson CG; Pisansky TM; Borges V; Lowenstein JR; McNulty S; Galvin JM; Followill DS; Timmerman RD; White JR; Xiao Y; Matuszak MM
Pract Radiat Oncol; 2016; 6(6):e291-e298. PubMed ID: 27345129
[TBL] [Abstract][Full Text] [Related]
14. Radiation oncology.
Hellman S; Weichselbaum RR
JAMA; 1996 Jun; 275(23):1852-3. PubMed ID: 8642748
[No Abstract] [Full Text] [Related]
15. Re-defining rectal volume and DVH for analysis of rectal morbidity risk after radiotherapy for early prostate cancer.
O'Donnell HE; Finnegan K; Eliades H; Oliveros S; Plowman PN
Br J Radiol; 2008 Apr; 81(964):327-32. PubMed ID: 18344276
[TBL] [Abstract][Full Text] [Related]
16. [Image-guided radiotherapy].
de Crevoisier R; Isambert A; Lisbona A; Bodez V; Marguet M; Lafay F; Remonnay R; Lagrange JL
Cancer Radiother; 2007 Nov; 11(6-7):296-304. PubMed ID: 17889585
[TBL] [Abstract][Full Text] [Related]
17. Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.
Hall WA; Bergom C; Thompson RF; Baschnagel AM; Vijayakumar S; Willers H; Li XA; Schultz CJ; Wilson GD; West CML; Capala J; Coleman CN; Torres-Roca JF; Weidhaas J; Feng FY
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):274-284. PubMed ID: 28964588
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma : A dosimetric comparison.
Adeberg S; Harrabi SB; Bougatf N; Bernhardt D; Rieber J; Koerber SA; Syed M; Sprave T; Mohr A; Abdollahi A; Haberer T; Combs SE; Herfarth K; Debus J; Rieken S
Strahlenther Onkol; 2016 Nov; 192(11):770-779. PubMed ID: 27334276
[TBL] [Abstract][Full Text] [Related]
19. Technology for Innovation in Radiation Oncology.
Chetty IJ; Martel MK; Jaffray DA; Benedict SH; Hahn SM; Berbeco R; Deye J; Jeraj R; Kavanagh B; Krishnan S; Lee N; Low DA; Mankoff D; Marks LB; Ollendorf D; Paganetti H; Ross B; Siochi RA; Timmerman RD; Wong JW
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):485-92. PubMed ID: 26460989
[TBL] [Abstract][Full Text] [Related]
20. Iodine-125 brachytherapy as upfront and salvage treatment for brain metastases : A comparative analysis.
Romagna A; Schwartz C; Egensperger R; Watson J; Tonn JC; Belka C; Kreth FW; Nachbichler SB
Strahlenther Onkol; 2016 Nov; 192(11):780-788. PubMed ID: 27349709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
